SlideShare a Scribd company logo
1 of 48
Case Scenario
 A New-born baby born with 2kg weight, baby’s
condition was well and stable.
 After 3 days of birth of baby, the mother has
noticed yellowish discoloration of the whole
body and sclera.
 During the first two days stools were said to be
dark in color which has turned clay color by the
3rd day .
NEONATAL JAUNDICE
Swaraj Suman
MSc. 1st year student
What is the Neonatal Jaundice?
Neonatal Jaundice(also called Newborn jaundice) is a
condition marked by high levels of bilirubin in the
blood.
 The increased bilirubin
cause the infant's skin
and whites of the eyes
(sclera) to look yellow.
Neonatal Jaundice
Visible form of bilirubinemia
›Adult sclera >2mg / dl
›Newborn skin >5 mg / dl
 Incidence
Occurs in 60% of term and 80% of preterm neonates
However, significant jaundice occurs in 6 % of term babies
Special characteristic in neonates
• 1.More bilirubin produced
• Much more Hemolysis
• The life-length of Hemolysis(70~80)
Special characteristic in neonates
• 2.The low capability of albumin on
unconjugated bilirubin transportation
• Acid intoxication
• Less albumin in neonates
Special characteristic in neonates
• 3.The low capability of hepatocyte
• The primary development of Hepato-enzyme system
• Easy-broken hepato-enzyme system
• After-born, the blood glucose level is very low.
Special characteristic in neonates
• 4.High workload of the hepato-enteric
circulation
• Less bacterial
• Low enzymatic activity in intestine
Increased RBC’s
Shortened RBC lifespan
Immature hepatic
uptake & conjugation
Increased enterohepatic
Circulation
Pathogenesis
Physiological jaundice
Characteristics
Appears after 24 hours
Maximum intensity by 4th-5th day in term & 7th day in
preterm
Serum level less than 15 mg / dl
Clinically not detectable after 14 days
Disappears without any treatment
Note: Baby should, however, be watched for worsening of jaundice
Teaching Aids:
N
J
-
1
1
Pathological jaundice
Appears within 24 hours of age
Increase of bilirubin > 5 mg / dl / day
Serum bilirubin > 15 mg / dl
Jaundice persisting after 14 days
Stool clay / white colored and urine staining
clothes yellow
Direct bilirubin> 2 mg / dl
Teaching Aids:
N
J
-
1
2
Difference between pathological
and physiological Jaundice ?????
Causes of jaundice
 Appearing within 24 hours of age
Hemolytic disease of NB : Rh, ABO
Infections: TORCH, malaria, bacterial
G6PD deficiency
 Appearing between 24-72 hours of life
Physiological
Sepsis
Polycythemia
Concealed hemorrhage
Intraventricular hemorrhage
Increased entero-hepatic circulation
Teaching Aids:
N
J
-
1
5
Causes of jaundice
 After 72 hours of age
Sepsis
Cephalo-hematoma
Neonatal hepatitis
Extra-hepatic biliary atresia
Breast milk jaundice
Metabolic disorders
Teaching Aids:
N
J
-
1
6
Common causes in India
Physiological
Blood group incompatibility
G6PD deficiency
Bruising and cephalo-hematoma
Intrauterine and postnatal infections
Breast milk jaundice
Teaching Aids:
N
J
-
1
7
Grading
Clinical assessment of jaundice
Area of body Bilirubin levels
mg/dl
Face 4-8
Upper trunk 5-12
Lower trunk & thighs 8-16
Arms and lower legs 11-18
Palms & soles > 15
Teaching Aids:
N
J
-
1
9
How to measure
 Use a TC bilirubinometer in babies with Gestational age of 35 weeks or
more and postnatal age of > 24 hours.
 If a TC bilirubinometer is not available, measure the serum bilirubin.
 If a TC bilirubinometer measurement > 250 umol/l (15 mg/dl) ………..
 Check the result by measuring the serum bilirubin.
Approach to jaundiced baby
o Birth weight
o Gestation and postnatal age
o Assess clinical condition (well or ill)
Physiological or Pathological
o Look for evidence of kernicterus* in deeply jaundiced
Newborn
o *Lethargy and poor feeding, poor or absent Moro's,
opisthotonos or convulsions.
Teaching Aids:
N
J
-
2
1
Diagnosis
Maternal & perinatal history
Physical examination
Laboratory tests (must in all)
›Total & direct bilirubin*
›Blood group and Rh for mother and baby*
›Hematocrit, retic count and peripheral smear*
›Sepsis screen
›Liver and thyroid function
›TORCH titers, Liver scan when conjugated hyperbilirubinemia
Teaching Aids:
N
J
-
2
2
Management
Rationale: reduce level of serum bilirubin and
prevent bilirubin toxicity
Prevention of hyperbilirubinemia: early feeds,
adequate hydration
Reduction of bilirubin levels: phototherapy,
Exchange transfusion, Drugs
Teaching Aids:
N
J
-
2
4
Mechanism of phototherapy
 Photo-oxidation
 Configurational isomerization- Water – soluble E-Z isomers
 Structural isomerization- lumirubin
 Out of 3 mechanism structural isomerization is most
effective.
Principle of phototherapy
Native bilirubin Photo isomers of
bilirubin
Insoluble Soluble
NJ - 26
460-490nm
of light
Phototherapy
Technique
Perform hand wash.
Place baby naked in cradle or incubator.
Fix eye shades/cover.
Keep baby at least 45 cm from lights.
Start phototherapy
N
J
-
2
7
Phototherapy
Frequent extra breast feeding every 2 hourly.
Turn baby after each feed.
Temperature record 2 to 4 hourly.
Weight record- daily.
Monitor urine frequency.
Monitor bilirubin level.
Key point in the practical execution
of phototherapy
1.The infant should be naked except for diaper , eye to be
covered
2. Distance between the skin and light source (30-45cm) .
3. When used spotlight , the infant is placed in centre .
4. Routinely add 10-15% extra fluid .
5. Timing of follow –up and serum bilirubin testing must
be individualized.
Lights used in phototherapy
 1. Micro white halogen Light
 2. Fluoro- 2 blue and 2 white fluorescent lights
 Types of Phototherapy unit
 Single surface unit
 Double surface unit
 Triple surface unit
Side effects of phototherapy
Increased insensible water loss
Loose stools
Skin rash
Bronze baby syndrome
Hyperthermia
Upsets maternal baby interaction
May result in hypocalcemia
Teaching Aids:
N
J
-
3
2
Exchange Transfusion
 Removing affected infants blood and simultaneously replacing
with aliquots of compatible donor blood.
 Aliquots of blood = Small volumes of blood
Indications
ABO incompatibility
Rh isoimmunization
Indirect serum bilirubin- 20mg/100 ml or more during first
5 days of life.
Septicemia
DIC
Life threatening metabolic disorders
Acute renal and hepatic failure
Poisoning
Symptomatic Polycythemia
Teaching Aids:
Method
1. Infants stomach should be emptied before transfusion to prevent aspiration.
2. Vital signs monitored.
3. With strict aseptic technique, the umbilical vein is cannulated with catheter.
4. Aspiration of 20ml of infant blood alternating with infusion of 20ml of donor
blood.
5. Goal- An isovolumetric exchange of approximately two blood volumes of the
infant .
Eg.- Double-volume exchange- 2 x blood volume = 2 x 80 cc/kg = 160 cc/kg
Choice of blood for exchange
blood transfusion
 ABO incompatibility
› Use O blood crossmatched against infant serum.
› In less severe cases- Identify ABO group of both mother and baby.
 Rh isoimmunization
› In Emergency- O Rh negative blood without crossmatching.
› In anticipated Rh sensitized infant birth- O Rh negative blood
crossmatched against maternal serum.
Criterions for Blood exchange transfusion :
 1. Transfuse blood as fresh as possible.
 2. Maintained at a temperature between 35 and 37° C throughout the
exchange transfusion.
 3. Kept well mixed and by gentle squeezing or agitation of the bag to
avoid sedimentation.
Types of exchange transfusion
 Three types of exchange transfusion are commonly used:
 A) Two- volume exchange
 B) Partial exchange ( For treatment polycythemia or anemia )
 C) Intrauterine exchanges
 A one volume exchange transfusion results in removal of 70% to 75% of the
neonates RBC.
 A two volume exchange replaces 90% the optimal volume for an exchange
transfusion is twice the infant’s blood volume.
Two- volume exchange
Contd..
 Traditionally, the rule of “10/30” was followed for RBC transfusion, according to
which a Hb level of 10 g/dl or a hematocrit of 30% was recommended in
surgical patients.
 Blood components must be transfused within 4 hours of issue.
 If the transfusion is interrupted for any reason, administration must be discontinued
after 4 hours even if the transfusion is not complete.
Complications of exchange transfusion
1. Anemia
2. Cholestasis
3. Inspissated bile syndrome
4. Portal vein thrombosis
5. Portal hypertension
DRUGS to treat neonatal jaundice
 Phenobarbitone - Induces liver enzymes-increases conjugation
 Metalloporphyrins- Inhibits heme oxygenase
 IVIG- Inhibits hemolysis
 Oral agar agar &cholestyramine- decreases entero-hepatic circulation
 Albumin infusions-increases bilirubin binding
Metalloporphyrins
 Metalloporphyrins are inhibitors of the rate-limiting enzyme,
heme oxygenase, in the pathway of heme degradation leading to
bilirubin production.
 Tin mesoporphyrin has been most extensively studied in
human infants and has been shown to reduce the need for
phototherapy.
Kernicterus
 Kernicterus is damage to the brain centers of infants
caused by increased levels of unconjugated-indirect
bilirubin which is free (not bound to albumin).
Journal Review
 Hyperbilirubinemia in Neonates: Types, Causes, Clinical Examinations, Preventive Measures and Treatments: A Narrative
Review Article
 2016(May) -Sana ULLAH,1 Khaista RAHMAN,2 and Mehdi HEDAYATI3,*
 Methods - The main databases including Scopus, Pubmed, MEDLINE, Google scholar and Science Direct were researched to
obtain the original papers related to the newborns’ hyperbilirubinemia. The main terms used to literature search were
“newborns’ hyperbilirubinemia”, “newborns’ jaundice”, “Physiological Jaundice” and “Patholigical Jaundice”.
 Results - Neonatal jaundice due to breast milk feeding is also sometimes observed. Hemolytic jaundice occurs because of
the incompatibility of blood groups with ABO and Rh factors, when the fetus and mother blood groups are not compatible
and the fetus blood crosses the barrier of the umbilical cord before birth causing fetus blood hemolysis owing to severe
immune response.
 Conclusion: Jaundice is easily diagnosable however require quick and on the spot treatment. If not treated properly, it leads
to many complications. Currently the treatment options for jaundice include photo therapy, chemotherapy, and vaccinations.
summary
Neonatal Jaundice: Causes, Symptoms and Treatment

More Related Content

What's hot

Neonatal Hypothermia
Neonatal HypothermiaNeonatal Hypothermia
Neonatal HypothermiaTheShraddha
 
Neonatal hypoglycemia
Neonatal hypoglycemia Neonatal hypoglycemia
Neonatal hypoglycemia Azad Haleem
 
Presentation on NRP (Neonatal Resuscitation Program)
Presentation on NRP (Neonatal Resuscitation Program)Presentation on NRP (Neonatal Resuscitation Program)
Presentation on NRP (Neonatal Resuscitation Program)Moninder Kaur
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundiceakifab93
 
Neonatal jaundice (hyperbilirubinemia) by Rajiv Mavachi
Neonatal jaundice (hyperbilirubinemia) by Rajiv MavachiNeonatal jaundice (hyperbilirubinemia) by Rajiv Mavachi
Neonatal jaundice (hyperbilirubinemia) by Rajiv MavachiRajiv Mavachi
 
Neonatologymcqs 100403011632-phpapp02
Neonatologymcqs 100403011632-phpapp02Neonatologymcqs 100403011632-phpapp02
Neonatologymcqs 100403011632-phpapp02AmarSETIA
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundicebskanthb
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundiceCSN Vittal
 
Neonatal Cold Injury Syndrome
Neonatal Cold Injury SyndromeNeonatal Cold Injury Syndrome
Neonatal Cold Injury Syndromeghalan
 
Management of hiperbilirubic infant final
Management of hiperbilirubic infant   finalManagement of hiperbilirubic infant   final
Management of hiperbilirubic infant finalkinjalisha
 
Surfactant replacement therapy : RDS & beyond
Surfactant replacement therapy : RDS & beyondSurfactant replacement therapy : RDS & beyond
Surfactant replacement therapy : RDS & beyondDr-Hasen Mia
 
Pathological jaundice
Pathological jaundicePathological jaundice
Pathological jaundiceTheShraddha
 
hypothermia in newborn.pptx
hypothermia in newborn.pptxhypothermia in newborn.pptx
hypothermia in newborn.pptxAnju Kumawat
 

What's hot (20)

Neonatal Jaundice
Neonatal JaundiceNeonatal Jaundice
Neonatal Jaundice
 
Neonatal Hypothermia
Neonatal HypothermiaNeonatal Hypothermia
Neonatal Hypothermia
 
Neonatal jaundice
Neonatal jaundice Neonatal jaundice
Neonatal jaundice
 
Neonatal hypoglycemia
Neonatal hypoglycemia Neonatal hypoglycemia
Neonatal hypoglycemia
 
Neonatal Jaundice
Neonatal JaundiceNeonatal Jaundice
Neonatal Jaundice
 
Presentation on NRP (Neonatal Resuscitation Program)
Presentation on NRP (Neonatal Resuscitation Program)Presentation on NRP (Neonatal Resuscitation Program)
Presentation on NRP (Neonatal Resuscitation Program)
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundice
 
Neonatal jaundice (hyperbilirubinemia) by Rajiv Mavachi
Neonatal jaundice (hyperbilirubinemia) by Rajiv MavachiNeonatal jaundice (hyperbilirubinemia) by Rajiv Mavachi
Neonatal jaundice (hyperbilirubinemia) by Rajiv Mavachi
 
Neonatologymcqs 100403011632-phpapp02
Neonatologymcqs 100403011632-phpapp02Neonatologymcqs 100403011632-phpapp02
Neonatologymcqs 100403011632-phpapp02
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundice
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundice
 
Neonatal Cold Injury Syndrome
Neonatal Cold Injury SyndromeNeonatal Cold Injury Syndrome
Neonatal Cold Injury Syndrome
 
neonatal jaundice
neonatal jaundiceneonatal jaundice
neonatal jaundice
 
Neonatal sepsis
Neonatal sepsisNeonatal sepsis
Neonatal sepsis
 
Management of hiperbilirubic infant final
Management of hiperbilirubic infant   finalManagement of hiperbilirubic infant   final
Management of hiperbilirubic infant final
 
Surfactant replacement therapy : RDS & beyond
Surfactant replacement therapy : RDS & beyondSurfactant replacement therapy : RDS & beyond
Surfactant replacement therapy : RDS & beyond
 
Apnea of prematurity
Apnea of prematurity Apnea of prematurity
Apnea of prematurity
 
Pathological jaundice
Pathological jaundicePathological jaundice
Pathological jaundice
 
Neonatal Apnea
Neonatal ApneaNeonatal Apnea
Neonatal Apnea
 
hypothermia in newborn.pptx
hypothermia in newborn.pptxhypothermia in newborn.pptx
hypothermia in newborn.pptx
 

Similar to Neonatal Jaundice: Causes, Symptoms and Treatment

Icterus neonatorum presentation for students
Icterus neonatorum presentation for studentsIcterus neonatorum presentation for students
Icterus neonatorum presentation for studentsNehaNupur8
 
Neonatal Jaundice.pptx
Neonatal Jaundice.pptxNeonatal Jaundice.pptx
Neonatal Jaundice.pptxMesfinShifara
 
RJ-JAUNDICE.pptx
RJ-JAUNDICE.pptxRJ-JAUNDICE.pptx
RJ-JAUNDICE.pptxRashi773374
 
Neonatal hyperbilirubinemia.pptx
Neonatal hyperbilirubinemia.pptxNeonatal hyperbilirubinemia.pptx
Neonatal hyperbilirubinemia.pptxssusere8f40d
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundiceArwa H
 
Neonatal jaundice presentation
Neonatal jaundice presentationNeonatal jaundice presentation
Neonatal jaundice presentationSHRUTISHARMA569
 
NEONATAL JAUNDICE PPT.pdf
NEONATAL JAUNDICE PPT.pdfNEONATAL JAUNDICE PPT.pdf
NEONATAL JAUNDICE PPT.pdfBashiniOmalka
 
Jaundice in children- for undergraduate MBBS paediatrics
Jaundice in children- for undergraduate MBBS paediatricsJaundice in children- for undergraduate MBBS paediatrics
Jaundice in children- for undergraduate MBBS paediatricsANJANA B.S.
 
Neonatal Jaundice.pptx
Neonatal Jaundice.pptxNeonatal Jaundice.pptx
Neonatal Jaundice.pptxYusra Khan
 
Newborn hyperbilirubinemia
Newborn hyperbilirubinemiaNewborn hyperbilirubinemia
Newborn hyperbilirubinemiaMusa Abusabha
 
jaundice-neonatal-11.ppt
jaundice-neonatal-11.pptjaundice-neonatal-11.ppt
jaundice-neonatal-11.pptAhmadEnjadat
 
Neonatal Hyperbilirubinemia final I.ppt
Neonatal Hyperbilirubinemia final I.pptNeonatal Hyperbilirubinemia final I.ppt
Neonatal Hyperbilirubinemia final I.pptJusticeYegon1
 
Case presentation on neonatal jaundice corrected
Case presentation on neonatal jaundice correctedCase presentation on neonatal jaundice corrected
Case presentation on neonatal jaundice correctedbnsdfernando
 

Similar to Neonatal Jaundice: Causes, Symptoms and Treatment (20)

Icterus neonatorum presentation for students
Icterus neonatorum presentation for studentsIcterus neonatorum presentation for students
Icterus neonatorum presentation for students
 
Neonatal Jaundice.pptx
Neonatal Jaundice.pptxNeonatal Jaundice.pptx
Neonatal Jaundice.pptx
 
RJ-JAUNDICE.pptx
RJ-JAUNDICE.pptxRJ-JAUNDICE.pptx
RJ-JAUNDICE.pptx
 
Hyperbilirubinemia
HyperbilirubinemiaHyperbilirubinemia
Hyperbilirubinemia
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundice
 
Neonatal hyperbilirubinemia.pptx
Neonatal hyperbilirubinemia.pptxNeonatal hyperbilirubinemia.pptx
Neonatal hyperbilirubinemia.pptx
 
NNJ.pptx
NNJ.pptxNNJ.pptx
NNJ.pptx
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundice
 
Neonatal jaundice presentation
Neonatal jaundice presentationNeonatal jaundice presentation
Neonatal jaundice presentation
 
Nursing care of_hyperbilirubinemia
Nursing care of_hyperbilirubinemiaNursing care of_hyperbilirubinemia
Nursing care of_hyperbilirubinemia
 
NEONATAL JAUNDICE PPT.pdf
NEONATAL JAUNDICE PPT.pdfNEONATAL JAUNDICE PPT.pdf
NEONATAL JAUNDICE PPT.pdf
 
Jaundice in children- for undergraduate MBBS paediatrics
Jaundice in children- for undergraduate MBBS paediatricsJaundice in children- for undergraduate MBBS paediatrics
Jaundice in children- for undergraduate MBBS paediatrics
 
Neonatal Jaundice.pptx
Neonatal Jaundice.pptxNeonatal Jaundice.pptx
Neonatal Jaundice.pptx
 
Newborn hyperbilirubinemia
Newborn hyperbilirubinemiaNewborn hyperbilirubinemia
Newborn hyperbilirubinemia
 
jaundice-neonatal-11.ppt
jaundice-neonatal-11.pptjaundice-neonatal-11.ppt
jaundice-neonatal-11.ppt
 
Neonatal Hyperbilirubinemia final I.ppt
Neonatal Hyperbilirubinemia final I.pptNeonatal Hyperbilirubinemia final I.ppt
Neonatal Hyperbilirubinemia final I.ppt
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundice
 
Yellow Baby
Yellow Baby Yellow Baby
Yellow Baby
 
Case presentation on neonatal jaundice corrected
Case presentation on neonatal jaundice correctedCase presentation on neonatal jaundice corrected
Case presentation on neonatal jaundice corrected
 
Neonatal jaundice
Neonatal jaundice Neonatal jaundice
Neonatal jaundice
 

More from SWARAJSUMAN

Adjustment reaction to school.pptx
Adjustment reaction to school.pptxAdjustment reaction to school.pptx
Adjustment reaction to school.pptxSWARAJSUMAN
 
Learning Disabilities.pptx
Learning Disabilities.pptxLearning Disabilities.pptx
Learning Disabilities.pptxSWARAJSUMAN
 
ROLE PLAY ..pptx
ROLE PLAY ..pptxROLE PLAY ..pptx
ROLE PLAY ..pptxSWARAJSUMAN
 
Nursing management of Preterm, Term, Post-term and IUGR Baby.pptx
Nursing management of Preterm, Term, Post-term and IUGR Baby.pptxNursing management of Preterm, Term, Post-term and IUGR Baby.pptx
Nursing management of Preterm, Term, Post-term and IUGR Baby.pptxSWARAJSUMAN
 
Growth and development of Toddler.pptx
Growth and development of Toddler.pptxGrowth and development of Toddler.pptx
Growth and development of Toddler.pptxSWARAJSUMAN
 
Special laws and ordinances of child.pptx
Special laws and ordinances of child.pptxSpecial laws and ordinances of child.pptx
Special laws and ordinances of child.pptxSWARAJSUMAN
 

More from SWARAJSUMAN (6)

Adjustment reaction to school.pptx
Adjustment reaction to school.pptxAdjustment reaction to school.pptx
Adjustment reaction to school.pptx
 
Learning Disabilities.pptx
Learning Disabilities.pptxLearning Disabilities.pptx
Learning Disabilities.pptx
 
ROLE PLAY ..pptx
ROLE PLAY ..pptxROLE PLAY ..pptx
ROLE PLAY ..pptx
 
Nursing management of Preterm, Term, Post-term and IUGR Baby.pptx
Nursing management of Preterm, Term, Post-term and IUGR Baby.pptxNursing management of Preterm, Term, Post-term and IUGR Baby.pptx
Nursing management of Preterm, Term, Post-term and IUGR Baby.pptx
 
Growth and development of Toddler.pptx
Growth and development of Toddler.pptxGrowth and development of Toddler.pptx
Growth and development of Toddler.pptx
 
Special laws and ordinances of child.pptx
Special laws and ordinances of child.pptxSpecial laws and ordinances of child.pptx
Special laws and ordinances of child.pptx
 

Recently uploaded

ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.arsicmarija21
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptxSherlyMaeNeri
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Atmosphere science 7 quarter 4 .........
Atmosphere science 7 quarter 4 .........Atmosphere science 7 quarter 4 .........
Atmosphere science 7 quarter 4 .........LeaCamillePacle
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfMr Bounab Samir
 
Planning a health career 4th Quarter.pptx
Planning a health career 4th Quarter.pptxPlanning a health career 4th Quarter.pptx
Planning a health career 4th Quarter.pptxLigayaBacuel1
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxChelloAnnAsuncion2
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Jisc
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfSpandanaRallapalli
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 

Recently uploaded (20)

ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptx
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
Atmosphere science 7 quarter 4 .........
Atmosphere science 7 quarter 4 .........Atmosphere science 7 quarter 4 .........
Atmosphere science 7 quarter 4 .........
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
 
Planning a health career 4th Quarter.pptx
Planning a health career 4th Quarter.pptxPlanning a health career 4th Quarter.pptx
Planning a health career 4th Quarter.pptx
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdf
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 

Neonatal Jaundice: Causes, Symptoms and Treatment

  • 1. Case Scenario  A New-born baby born with 2kg weight, baby’s condition was well and stable.  After 3 days of birth of baby, the mother has noticed yellowish discoloration of the whole body and sclera.  During the first two days stools were said to be dark in color which has turned clay color by the 3rd day .
  • 3. What is the Neonatal Jaundice? Neonatal Jaundice(also called Newborn jaundice) is a condition marked by high levels of bilirubin in the blood.  The increased bilirubin cause the infant's skin and whites of the eyes (sclera) to look yellow.
  • 4. Neonatal Jaundice Visible form of bilirubinemia ›Adult sclera >2mg / dl ›Newborn skin >5 mg / dl  Incidence Occurs in 60% of term and 80% of preterm neonates However, significant jaundice occurs in 6 % of term babies
  • 5.
  • 6. Special characteristic in neonates • 1.More bilirubin produced • Much more Hemolysis • The life-length of Hemolysis(70~80)
  • 7. Special characteristic in neonates • 2.The low capability of albumin on unconjugated bilirubin transportation • Acid intoxication • Less albumin in neonates
  • 8. Special characteristic in neonates • 3.The low capability of hepatocyte • The primary development of Hepato-enzyme system • Easy-broken hepato-enzyme system • After-born, the blood glucose level is very low.
  • 9. Special characteristic in neonates • 4.High workload of the hepato-enteric circulation • Less bacterial • Low enzymatic activity in intestine
  • 10. Increased RBC’s Shortened RBC lifespan Immature hepatic uptake & conjugation Increased enterohepatic Circulation Pathogenesis
  • 11. Physiological jaundice Characteristics Appears after 24 hours Maximum intensity by 4th-5th day in term & 7th day in preterm Serum level less than 15 mg / dl Clinically not detectable after 14 days Disappears without any treatment Note: Baby should, however, be watched for worsening of jaundice Teaching Aids: N J - 1 1
  • 12. Pathological jaundice Appears within 24 hours of age Increase of bilirubin > 5 mg / dl / day Serum bilirubin > 15 mg / dl Jaundice persisting after 14 days Stool clay / white colored and urine staining clothes yellow Direct bilirubin> 2 mg / dl Teaching Aids: N J - 1 2
  • 13. Difference between pathological and physiological Jaundice ?????
  • 14.
  • 15. Causes of jaundice  Appearing within 24 hours of age Hemolytic disease of NB : Rh, ABO Infections: TORCH, malaria, bacterial G6PD deficiency  Appearing between 24-72 hours of life Physiological Sepsis Polycythemia Concealed hemorrhage Intraventricular hemorrhage Increased entero-hepatic circulation Teaching Aids: N J - 1 5
  • 16. Causes of jaundice  After 72 hours of age Sepsis Cephalo-hematoma Neonatal hepatitis Extra-hepatic biliary atresia Breast milk jaundice Metabolic disorders Teaching Aids: N J - 1 6
  • 17. Common causes in India Physiological Blood group incompatibility G6PD deficiency Bruising and cephalo-hematoma Intrauterine and postnatal infections Breast milk jaundice Teaching Aids: N J - 1 7
  • 19. Clinical assessment of jaundice Area of body Bilirubin levels mg/dl Face 4-8 Upper trunk 5-12 Lower trunk & thighs 8-16 Arms and lower legs 11-18 Palms & soles > 15 Teaching Aids: N J - 1 9
  • 20. How to measure  Use a TC bilirubinometer in babies with Gestational age of 35 weeks or more and postnatal age of > 24 hours.  If a TC bilirubinometer is not available, measure the serum bilirubin.  If a TC bilirubinometer measurement > 250 umol/l (15 mg/dl) ………..  Check the result by measuring the serum bilirubin.
  • 21. Approach to jaundiced baby o Birth weight o Gestation and postnatal age o Assess clinical condition (well or ill) Physiological or Pathological o Look for evidence of kernicterus* in deeply jaundiced Newborn o *Lethargy and poor feeding, poor or absent Moro's, opisthotonos or convulsions. Teaching Aids: N J - 2 1
  • 22. Diagnosis Maternal & perinatal history Physical examination Laboratory tests (must in all) ›Total & direct bilirubin* ›Blood group and Rh for mother and baby* ›Hematocrit, retic count and peripheral smear* ›Sepsis screen ›Liver and thyroid function ›TORCH titers, Liver scan when conjugated hyperbilirubinemia Teaching Aids: N J - 2 2
  • 23.
  • 24. Management Rationale: reduce level of serum bilirubin and prevent bilirubin toxicity Prevention of hyperbilirubinemia: early feeds, adequate hydration Reduction of bilirubin levels: phototherapy, Exchange transfusion, Drugs Teaching Aids: N J - 2 4
  • 25. Mechanism of phototherapy  Photo-oxidation  Configurational isomerization- Water – soluble E-Z isomers  Structural isomerization- lumirubin  Out of 3 mechanism structural isomerization is most effective.
  • 26. Principle of phototherapy Native bilirubin Photo isomers of bilirubin Insoluble Soluble NJ - 26 460-490nm of light
  • 27. Phototherapy Technique Perform hand wash. Place baby naked in cradle or incubator. Fix eye shades/cover. Keep baby at least 45 cm from lights. Start phototherapy N J - 2 7
  • 28. Phototherapy Frequent extra breast feeding every 2 hourly. Turn baby after each feed. Temperature record 2 to 4 hourly. Weight record- daily. Monitor urine frequency. Monitor bilirubin level.
  • 29. Key point in the practical execution of phototherapy 1.The infant should be naked except for diaper , eye to be covered 2. Distance between the skin and light source (30-45cm) . 3. When used spotlight , the infant is placed in centre . 4. Routinely add 10-15% extra fluid . 5. Timing of follow –up and serum bilirubin testing must be individualized.
  • 30. Lights used in phototherapy  1. Micro white halogen Light  2. Fluoro- 2 blue and 2 white fluorescent lights  Types of Phototherapy unit  Single surface unit  Double surface unit  Triple surface unit
  • 31.
  • 32. Side effects of phototherapy Increased insensible water loss Loose stools Skin rash Bronze baby syndrome Hyperthermia Upsets maternal baby interaction May result in hypocalcemia Teaching Aids: N J - 3 2
  • 33. Exchange Transfusion  Removing affected infants blood and simultaneously replacing with aliquots of compatible donor blood.  Aliquots of blood = Small volumes of blood
  • 34. Indications ABO incompatibility Rh isoimmunization Indirect serum bilirubin- 20mg/100 ml or more during first 5 days of life. Septicemia DIC Life threatening metabolic disorders Acute renal and hepatic failure Poisoning Symptomatic Polycythemia Teaching Aids:
  • 35. Method 1. Infants stomach should be emptied before transfusion to prevent aspiration. 2. Vital signs monitored. 3. With strict aseptic technique, the umbilical vein is cannulated with catheter. 4. Aspiration of 20ml of infant blood alternating with infusion of 20ml of donor blood. 5. Goal- An isovolumetric exchange of approximately two blood volumes of the infant . Eg.- Double-volume exchange- 2 x blood volume = 2 x 80 cc/kg = 160 cc/kg
  • 36. Choice of blood for exchange blood transfusion  ABO incompatibility › Use O blood crossmatched against infant serum. › In less severe cases- Identify ABO group of both mother and baby.  Rh isoimmunization › In Emergency- O Rh negative blood without crossmatching. › In anticipated Rh sensitized infant birth- O Rh negative blood crossmatched against maternal serum.
  • 37. Criterions for Blood exchange transfusion :  1. Transfuse blood as fresh as possible.  2. Maintained at a temperature between 35 and 37° C throughout the exchange transfusion.  3. Kept well mixed and by gentle squeezing or agitation of the bag to avoid sedimentation.
  • 38. Types of exchange transfusion  Three types of exchange transfusion are commonly used:  A) Two- volume exchange  B) Partial exchange ( For treatment polycythemia or anemia )  C) Intrauterine exchanges  A one volume exchange transfusion results in removal of 70% to 75% of the neonates RBC.  A two volume exchange replaces 90% the optimal volume for an exchange transfusion is twice the infant’s blood volume.
  • 40. Contd..  Traditionally, the rule of “10/30” was followed for RBC transfusion, according to which a Hb level of 10 g/dl or a hematocrit of 30% was recommended in surgical patients.  Blood components must be transfused within 4 hours of issue.  If the transfusion is interrupted for any reason, administration must be discontinued after 4 hours even if the transfusion is not complete.
  • 41. Complications of exchange transfusion 1. Anemia 2. Cholestasis 3. Inspissated bile syndrome 4. Portal vein thrombosis 5. Portal hypertension
  • 42. DRUGS to treat neonatal jaundice  Phenobarbitone - Induces liver enzymes-increases conjugation  Metalloporphyrins- Inhibits heme oxygenase  IVIG- Inhibits hemolysis  Oral agar agar &cholestyramine- decreases entero-hepatic circulation  Albumin infusions-increases bilirubin binding
  • 43. Metalloporphyrins  Metalloporphyrins are inhibitors of the rate-limiting enzyme, heme oxygenase, in the pathway of heme degradation leading to bilirubin production.  Tin mesoporphyrin has been most extensively studied in human infants and has been shown to reduce the need for phototherapy.
  • 44. Kernicterus  Kernicterus is damage to the brain centers of infants caused by increased levels of unconjugated-indirect bilirubin which is free (not bound to albumin).
  • 45. Journal Review  Hyperbilirubinemia in Neonates: Types, Causes, Clinical Examinations, Preventive Measures and Treatments: A Narrative Review Article  2016(May) -Sana ULLAH,1 Khaista RAHMAN,2 and Mehdi HEDAYATI3,*  Methods - The main databases including Scopus, Pubmed, MEDLINE, Google scholar and Science Direct were researched to obtain the original papers related to the newborns’ hyperbilirubinemia. The main terms used to literature search were “newborns’ hyperbilirubinemia”, “newborns’ jaundice”, “Physiological Jaundice” and “Patholigical Jaundice”.  Results - Neonatal jaundice due to breast milk feeding is also sometimes observed. Hemolytic jaundice occurs because of the incompatibility of blood groups with ABO and Rh factors, when the fetus and mother blood groups are not compatible and the fetus blood crosses the barrier of the umbilical cord before birth causing fetus blood hemolysis owing to severe immune response.  Conclusion: Jaundice is easily diagnosable however require quick and on the spot treatment. If not treated properly, it leads to many complications. Currently the treatment options for jaundice include photo therapy, chemotherapy, and vaccinations.
  • 46.